GERM vs. HELX ETF Comparison
Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Franklin Genomic Advancements ETF (HELX)
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.
Grade (RS Rating)
Last Trade
$19.16
Average Daily Volume
1,248
Number of Holdings
*
2
* may have additional holdings in another (foreign) market
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$32.02
Average Daily Volume
2,284
Number of Holdings
*
49
* may have additional holdings in another (foreign) market
Performance
Period | GERM | HELX |
---|---|---|
30 Days | 3.00% | -3.78% |
60 Days | 3.68% | -2.32% |
90 Days | -2.06% | 2.25% |
12 Months | -0.17% | 15.70% |
0 Overlapping Holdings
Symbol | Grade | Weight in GERM | Weight in HELX | Overlap |
---|
GERM Underweight 49 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
MEDP | F | -5.6% | |
VRTX | D | -5.35% | |
DHR | C | -5.34% | |
REGN | D | -5.19% | |
TMO | C | -5.09% | |
LLY | D | -4.9% | |
KRYS | D | -4.27% | |
NTRA | A | -3.82% | |
AZN | D | -2.67% | |
BRKR | D | -2.32% | |
CTVA | A | -2.22% | |
A | B | -2.21% | |
IONS | F | -2.18% | |
INSM | D | -2.06% | |
CDNS | D | -2.05% | |
CRL | F | -1.95% | |
QGEN | D | -1.94% | |
BNTX | B | -1.89% | |
ALNY | C | -1.83% | |
UTHR | C | -1.77% | |
EXAS | C | -1.68% | |
ICLR | F | -1.6% | |
SRPT | F | -1.56% | |
RCKT | F | -1.49% | |
RARE | C | -1.41% | |
TWST | D | -1.26% | |
IQV | F | -1.13% | |
TECH | C | -1.01% | |
AZTA | F | -0.96% | |
MRNA | F | -0.92% | |
CDMO | C | -0.88% | |
BEAM | F | -0.88% | |
BBIO | F | -0.86% | |
NBIX | F | -0.82% | |
LGND | D | -0.82% | |
NTLA | F | -0.81% | |
VYGR | F | -0.81% | |
CRSP | F | -0.63% | |
RXRX | F | -0.62% | |
FDMT | F | -0.57% | |
RGEN | F | -0.56% | |
AVTR | D | -0.52% | |
BIO | B | -0.51% | |
BMY | B | -0.29% | |
SLP | F | -0.28% | |
VCYT | C | -0.24% | |
BMRN | F | -0.21% | |
DVAX | D | -0.19% | |
ARE | D | -0.16% |
GERM: Top Represented Industries & Keywords
Industries:
Biotechnology
Drug Manufacturers - General
HELX: Top Represented Industries & Keywords